Welch Group’s Celgene Corp CELG Stock Holding History

Welch Group’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-1,196	Closed	-$174K	–	145
2017 Q3	$174K	Hold	1,196	–	–	0.03%	99
2017 Q2	$155K	Hold	1,196	–	–	0.03%	132
2017 Q1	$149K	Hold	1,196	–	–	0.03%	98
2016 Q4	$138K	Hold	1,196	–	–	0.03%	117
2016 Q3	$125K	Hold	1,196	–	–	0.02%	123
2016 Q2	$118K	Hold	1,196	–	–	0.02%	113
2016 Q1	$120K	Hold	1,196	–	–	0.02%	137
2015 Q4	$143K	Hold	1,196	–	–	0.03%	127
2015 Q3	$129K	Sell	1,196 -600	-33%	-$74.5K	0.02%	130
2015 Q2	$208K	Hold	1,796	–	–	0.04%	105
2015 Q1	$207	Buy	1,796 +600	+50%	+$71.7K	0.04%	106
2014 Q4	$134K	Hold	1,196	–	–	0.03%	130
2014 Q3	$113K	Hold	1,196	–	–	0.02%	135
2014 Q2	$103K	Buy	+1,196	New	+$91K	0.02%	142
2014 Q1	–	Sell	-1,196	Closed	-$101K	–	134
2013 Q4	$101K	Buy	+1,196	New	+$94.6K	0.02%	129

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Welch Group's CELG Position: Q4 2017 in Review

Welch Group sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 1,196 shares — an estimated $174K sold.

Welch Group first reported a position in CELG in Q4 2013 and held it in 15 quarters. The position peaked at $208K in Q2 2015. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

Welch Group reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
Welch Group sold 1,196 Celgene Corp shares in Q4 2017, an estimated $174K.
Welch Group first reported a position in Celgene Corp in Q4 2013 and held it in 15 quarters.
Welch Group's Celgene Corp position peaked at $208K in Q2 2015.
1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Welch Group's 13F filing for Q4 2017, filed 1 Feb 2018.